Showing results (141-150 of 230) with videos related to

Sort By:
Pageof 23
Cancer Research Communications|November 16, 2022
Na+/H+-exchanger 1 enhances antitumor activity of engineered NK-92 natural killer cellsYao-Yu Gong, Hongguang Shao, Yu Li, et al.
Cancer Gene Therapy|April 30, 2003
Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killingRainer Wiewrodt, Kunjlata Amin, Michael Kiefer, et al.
Blood|November 30, 2007
Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculatureBi-Sen Ding, Nankang Hong, Juan-Carlos Murciano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2011
Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptorEdmund K Moon, Carmine Carpenito, Jing Sun, et al.
Cancer Research|September 24, 2009
Expression of IFN-beta enhances both efficacy and safety of oncolytic vesicular stomatitis virus for therapy of mesotheliomaCandice L Willmon, Vassiliki Saloura, Zvi G Fridlender, et al.
Critical Care Medicine|October 2, 2008
Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major traumaJason D Christie, Shwu-Fan Ma, Richard Aplenc, et al.
Cancer Research|March 3, 2007
A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resectionEiji Suzuki, Samuel Kim, H-Kam Cheung, et al.
Cancer Biology & Therapy|April 23, 2005
Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinomaPeter DeLong, Richard G Carroll, Adam C Henry, et al.
Cancer Research|September 17, 2005
Intrapulmonary IFN-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lungMichael J Wilderman, Jing Sun, Arminder S Jassar, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2021
Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trialSharyn I Katz, Leonid Roshkovan, Ian Berger, et al.
Pageof 23